Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
GSKVX000000025896
- Development stage
- Unknown
- Lead developer
- GSK
- Modality
- Vaccines & Immunotherapeutics
- Administration
- Intramuscular
01
Overview
GSKVX000000025896 is an investigational live-attenuated varicella vaccine developed by GSK, specifically designed for intramuscular (IM) administration. It is currently in Phase 3 clinical development (e.g., trial 2024-518840-18-00) for the prevention of varicella (chickenpox) in healthy toddlers aged 12 to 15 months. The vaccine is being evaluated for its immunogenicity and safety when co-administered with GSK's MMR vaccine, Priorix, and is compared against established subcutaneous varicella vaccines like Varivax. The intramuscular route is intended to offer a more standardized and potentially more convenient administration method compared to the traditional subcutaneous route used for most varicella vaccines.
- Other names
- GSK investigational varicella vaccineGSK varicella vaccine (IM formulation)
Beyond the preview
Go deeper on GSKVX000000025896.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on GSKVX000000025896.